{"entities":{"Q9816":{"pageid":13977,"ns":120,"title":"Item:Q9816","lastrevid":205737,"modified":"2020-05-21T15:45:13Z","type":"item","id":"Q9816","labels":{"en":{"language":"en","value":"Postema EJ, et al. J. Nucl. Med. (2003) cited as Ref 553 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9816$C40BE69A-6899-4AAC-8585-B6D4D93DCA9F","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9816$6539C039-B158-42B7-946F-5CA9B5CD496B","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Postema EJ","type":"string"},"datatype":"string"},"type":"statement","id":"Q9816$632462A3-A26C-4E29-A38E-7866161BF0AF","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"14530488","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9816$C582F910-EDF2-4313-910F-90DC5AA3BC43","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2003-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9816$9B1BC4F6-AA3D-472E-8B9F-E0F4AAC1B71D","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"J. Nucl. Med.","type":"string"},"datatype":"string"},"type":"statement","id":"Q9816$C91A7870-28EA-4953-B4A0-8E3D12A80FFB","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"44","type":"string"},"datatype":"string"},"type":"statement","id":"Q9816$FA08B448-2B92-4890-8EAA-7DB1D68EF51C","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"Dosimetric analysis of radioimmunotherapy with 186Re-labeled bivatuzumab in patients with head and neck cancer","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9816$8B6C5D89-E0E5-4043-8348-4D34997132FB","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"1690-1699","type":"string"},"datatype":"string"},"type":"statement","id":"Q9816$926C30AF-06D7-4F28-8E51-03B6A5B98F30","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Postema EJ, et al. J. Nucl. Med. (2003) cited as Ref 553 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Postema_EJ,_et_al._J._Nucl._Med._(2003)_cited_as_Ref_553_in_DOI:_10.1038/s41392-020-0110-5"}}}}}